Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.0
-8x
40%
—
23x
80%
—
5 Years
Score4.0
Net Growth-8x
Net Trend40%
Net Income Consistency—
Rev Growth23x
Rev Trend80%
Revenue Consistency—
Mirum Pharmaceuticals Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 11M to $ 521M and net income went from -$ 103M to -$ 23M. Revenue increased in 4 of those 5 years; net income in 2.
Mirum Pharmaceuticals Inc currently holds a 5-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 98.97 | — |
1 Year2025-08-12 | $ 64.72 | 52.92% |
5 Years2021-08-12 | $ 14.19 | 6x |
All Time2019-07-18 | $ 13.21 | 7x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-07-18 |
|---|---|---|---|---|
| Price | $ 98.97 | $ 64.72 | $ 14.19 | $ 13.21 |
| Return | — | 52.92% | 6x | 7x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 441M | -$ 860M | $ 438M |
| 2025 | $ 521M | -$ 23M | $ 383M |
| 2024 | $ 336M | -$ 87M | $ 280M |
| 2023 | $ 186M | -$ 163M | $ 286M |
| 2022 | $ 77M | -$ 135M | $ 151M |
| 2021 | $ 19M | -$ 83M | $ 156M |
| 2020 | $ 11M | -$ 103M | $ 231M |
| IPO2019 | $ 0.00 | -$ 52M | $ 116M |
Explore beyond MIRM
You're looking at Mirum Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
